Two molecularly different Papilloma-Carcinoma-sequence could be hypothesized, either driven by EGFR or KRAS mutations and a secondary event as, for example, a TP53 mutation leading to invasive carcinoma. The gene discussed is KRAS; the disease is carcinoma.